Hemostatic Markers, Adamts-13 Profile and Anti-Sars-Cov-2 Antibody Levels in Patients with Immune Thrombotic Thrombocytopenic Purpura Receiving BNT162b2 Vaccination

Introduction: Patients (pts) with immune thrombotic thrombocytopenic purpura (iTTP) are at high risk of severe COVID-19, therefore protection from SARS-CoV-2 by vaccination is particularly relevant in this setting, although concerns may exist on possible adverse reactions or disease relapse after va...

Descripción completa

Detalles Bibliográficos
Autores principales: Schieppati, Francesca, Russo, Laura, Marchetti, Marina, Galimberti, Elisa, Palladino, Angela Maria, Gamba, Sara, Verzeroli, Cristina, Tartari, Carmen Julia J, Bolognini, Silvia, Ticozzi, Chiara, Giaccherini, Cinzia, Barcella, Luca, Falanga, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
311.Disorders of Platelet Number or Function: Clinical and Epidemiological
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701612/
http://dx.doi.org/10.1182/blood-2021-153606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701612/
http://dx.doi.org/10.1182/blood-2021-153606

Ejemplares similares